Literature DB >> 11067936

CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis.

S Thoma-Uszynski1, S Stenger, R L Modlin.   

Abstract

Two subsets of human CTL have been defined based upon phenotype and function: CD4(-) CD8(-) double-negative (DN) CTL lyse susceptible targets via Fas-Fas ligand interaction and CD8(+) CTL via the granule exocytosis pathway. CD8(+) CTL, but not DN CTL, can mediate an antimicrobial activity against Mycobacterium tuberculosis-infected target cells that is dependent on cytotoxic granules that contain granulysin. We investigated the role of nuclear apoptosis for the antimicrobial effector function of CD1-restricted CTL using the caspase inhibitor N:-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone. We found that DN CTL-induced target cell lysis was completely dependent on caspase activation, whereas the cytolytic activity of CD8(+) CTL was caspase independent. However, both DN and CD8(+) CTL-induced nuclear apoptosis required caspase activation. More important, the antimicrobial effector function of CD8(+) CTL was not diminished by inhibition of caspase activity. These data indicate that target cell nuclear apoptosis is not a requirement for CTL-mediated killing of intracellular M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067936     DOI: 10.4049/jimmunol.165.10.5773

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Mycobacteria and innate cells: critical encounter for immunogenicity.

Authors:  Angelo Martino
Journal:  J Biosci       Date:  2008-03       Impact factor: 1.826

2.  Human yeast-specific CD8 T lymphocytes show a nonclassical effector molecule profile.

Authors:  Tanja Breinig; Nicoletta Scheller; Birgit Glombitza; Frank Breinig; Andreas Meyerhans
Journal:  Med Microbiol Immunol       Date:  2011-09-25       Impact factor: 3.402

3.  Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts.

Authors:  Claudia Carranza; Esmeralda Juárez; Martha Torres; Jerrold J Ellner; Eduardo Sada; Stephan K Schwander
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

4.  Functional characterization of a T-cell receptor BV6+ T-cell clone derived from a leprosy lesion.

Authors:  Shereen Sabet; Maria-Teresa Ochoa; Peter A Sieling; Thomas H Rea; Robert L Modlin
Journal:  Immunology       Date:  2006-11-28       Impact factor: 7.397

5.  Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes.

Authors:  Michael Walch; Farokh Dotiwala; Sachin Mulik; Jerome Thiery; Tomas Kirchhausen; Carol Clayberger; Alan M Krensky; Denis Martinvalet; Judy Lieberman
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

Review 6.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

7.  TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.

Authors:  Haishan Li; Kun Luo; C David Pauza
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis.

Authors:  S S De La Barrera; M Finiasz; A Frias; M Alemán; P Barrionuevo; S Fink; M C Franco; E Abbate; M del C Sasiain
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

9.  Comparative analysis of mycobacterial heat shock proteins-induced apoptosis of peripheral blood mononuclear cells in sarcoidosis and tuberculosis.

Authors:  Anna Dubaniewicz; Piotr Trzonkowski; Mirosława Dubaniewicz-Wybieralska; Ada Dubaniewicz; Mahavir Singh; Andrzej Myśliwski
Journal:  J Clin Immunol       Date:  2006-03-21       Impact factor: 8.317

10.  Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function.

Authors:  Ken Hashimoto; Yumi Maeda; Hiroaki Kimura; Koichi Suzuki; Akihiro Masuda; Masanori Matsuoka; Masahiko Makino
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.